These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Acute generalized exanthematic pustulosis induced by spiramycin : usefulness of patch testing. Kastalli S; Charfi O; El Aïdli S; Zaïem A; Daghfous R Tunis Med; 2016 Jul; 94(7):339. PubMed ID: 28051238 [No Abstract] [Full Text] [Related]
3. [Co-sensitization to drugs belonging to different chemical classes during the same episode of cutaneous adverse drug reaction: two cases]. Dellestable P; Weber-Muller F; Tréchot P; Vernassière C; Schmutz JL; Barbaud A Ann Dermatol Venereol; 2007; 134(8-9):655-8. PubMed ID: 17925689 [TBL] [Abstract][Full Text] [Related]
4. Hypersensitivity to spiramycin with good tolerance of other macrolides. Sánchez-Morillas L; Laguna-Martínez JJ; Reaño-Martos M; Rojo-Andrés E; Gómez-Tembleque P; Santaolalla-Montoya M J Investig Allergol Clin Immunol; 2007; 17(6):417-8. PubMed ID: 18088029 [No Abstract] [Full Text] [Related]
5. Fixed drug eruption on the tongue due to clarithromycin. Alonso JC; Melgosa AC; Gonzalo MJ; García CM Contact Dermatitis; 2005 Aug; 53(2):121-2. PubMed ID: 16033413 [No Abstract] [Full Text] [Related]
6. A method for at-home lesional testing for fixed drug eruption. Hanson JL; Warshaw EM Dermatitis; 2015; 26(3):148. PubMed ID: 25984693 [No Abstract] [Full Text] [Related]
7. Adverse cutaneous reactions due to macrolides. Igea JM; Quirce S; de la Hoz B; Fraj J; Pola J; Diez Gomez ML Ann Allergy; 1991 Mar; 66(3):216-8. PubMed ID: 1706568 [TBL] [Abstract][Full Text] [Related]
8. Ciprofloxacin-induced acute generalized exanthematous pustulosis mimicking bullous drug eruption confirmed by a positive patch test. Hausermann P; Scherer K; Weber M; Bircher AJ Dermatology; 2005; 211(3):277-80. PubMed ID: 16205075 [TBL] [Abstract][Full Text] [Related]
10. Fixed drug eruption: a selective reaction to amoxicillin. Chaabane A; Fredj NB; Chadly Z; Boughattas NA; Aouam K Therapie; 2013; 68(3):183-5. PubMed ID: 23886467 [No Abstract] [Full Text] [Related]
11. Fixed drug eruption from clarithromycin. Rosina P; Chieregato C; Schena D Contact Dermatitis; 1998 Feb; 38(2):105. PubMed ID: 9506224 [No Abstract] [Full Text] [Related]
12. The potential utility of patch testing in identifying the causative agent of morbilliform drug eruptions. Endo JO; Davis C; Powell DL Dermatitis; 2011; 22(2):114-5. PubMed ID: 21504698 [No Abstract] [Full Text] [Related]
13. Nonpigmenting and pigmenting fixed drug eruptions due to clarithromycin. Asano A; Sowa-Osako J; Umekoji-Hayashi A; Teramae A; Fukai K; Tsuruta D Contact Dermatitis; 2021 Nov; 85(5):590-591. PubMed ID: 34129244 [No Abstract] [Full Text] [Related]
14. The use of patch tests in the diagnosis of delayed hypersensitivity drug eruptions. Hassoun-Kheir N; Bergman R; Weltfriend S Int J Dermatol; 2016 Nov; 55(11):1219-1224. PubMed ID: 27368159 [TBL] [Abstract][Full Text] [Related]
15. DRESS syndrome from cefadroxil confirmed by positive patch test. ; Hernanto M; Yudani BA; Pudjiati SR; Indrastuti N Allergy; 2007 Oct; 62(10):1216-7. PubMed ID: 17578496 [No Abstract] [Full Text] [Related]